Navigation Links
HIV Drug Combo May Help Prevent Malaria Reinfection
Date:11/28/2012

WEDNESDAY, Nov. 28 (HealthDay News) -- Treatment with a combination of certain HIV drugs greatly reduces the risk of recurrent malaria in children with HIV who are also being treated with drugs to prevent the mosquito-borne infection, according to new research.

The study included more than 170 HIV-positive infants and children up to 6 years old in Uganda who were receiving anti-malarial drugs and HIV treatment, including either a combination of the protease inhibitors lopinavir and ritonavir, or a class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs).

Despite the anti-malarial drugs and other preventive measures -- such as mosquito nets -- the children's risk of developing malaria during their first six months of HIV treatment was more than 40 percent. The risk during that time period was about the same whether the children were taking the protease inhibitors or an NNRTI, the investigators found.

However, among children who developed malaria and were successfully treated for it, 41 percent of those taking an NNRTI had a recurrence of malaria within 28 days compared with 14 percent of those taking the protease inhibitors.

And after 63 days, malaria recurrence had occurred among 54 percent of those taking an NNRTI and 28 percent of those taking the protease inhibitors, the research showed.

Blood levels of anti-malarial drugs in children taking the protease inhibitors were higher than in those taking an NNRTI, the researchers said.

The study, published Nov. 29 in the New England Journal of Medicine, was funded by the U.S. National Institute of Child Health and Human Development.

"It's possible that these protease inhibitors prevent anti-malarial drugs from breaking down or have some other additive effect against the malarial parasite," Dr. Lynne Mofenson, chief of the Pediatric, Adolescent, and Maternal AIDS Branch at the NICHD, said in an institute news release.

"Laboratory studies also suggest that protease inhibitors can block the malaria parasite outright. Finding out why this drug combination is effective is an area for further study," she added.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about malaria.

-- Robert Preidt

SOURCE: U.S. National Institute of Child Health and Human Development, news release, Nov. 28, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Being neurotic, and conscientious, a good combo for health
2. PI3-kinase and PARP inhibitor combo may offer new treatment option for triple-neg breast cancers
3. Cooking-Oil Combo May Improve Blood Pressure
4. Double drug combo could shut down abnormal blood vessel growth that feeds disease
5. Drug combo better for common type of metastatic breast cancer, UCI-led study finds
6. Booze, Energy Drinks, Casual Sex Combo Common in College: Study
7. FDA Approves Combo Shot for Meningitis, Hib in Kids
8. Combo Therapy May Help Ease Ringing in the Ears
9. Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
10. Two-Drug Combo May Be Safe for Melanoma Treatment
11. Two-Drug Combo Helps Teens With Migraines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Drug Combo May Help Prevent Malaria Reinfection
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids ... Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, ... run is geared towards children of all ages; it is a non-competitive, non-timed event, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
Breaking Medicine Technology: